🔗 Permalink

Inventor profile of:

Philipp WAGNER

City:

Stuttgart

Country:

Germany

Published Applications:

Last publication date:

2022-11-10

Top Assignees for applications by Philipp WAGNER

The entities that hold a legal rights for patent applications filed by inventor WAGNER Philipp:

IMMATICS BIOTECHNOLOGIES GMBH 21 Tuebingen, Germany

Recent patent applications by WAGNER Philipp

Philipp WAGNER from Stuttgart, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-11-10

US20220356227A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2 | 2022-02-15

US17345211

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#3 | 2021-11-25

US20210363221A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#4 | 2021-11-04

US20210340217A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#5 | 2021-11-04

US20210340216A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#6 | 2021-08-26

US20210260123A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#7 | 2021-08-26

US20210260122A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#8 | 2021-08-19

US20210252066A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#9 | 2021-08-19

US20210252065A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#10 | 2021-08-19

US20210252064A1

Human necessities

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#11 | 2021-04-15

US20210106624A1

Human necessities

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#12 | 2021-04-15

US20210106623A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#13 | 2021-04-08

US20210101957A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#14 | 2021-01-14

US20210009654A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#15 | 2020-10-08

US20200316127A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#16 | 2020-10-08

US20200316126A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#17 | 2020-10-08

US20200316125A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#18 | 2020-05-21

US20200155603A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#19 | 2020-01-02

US20200000850A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#20 | 2020-01-02

US20200000849A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#21 | 2019-12-19

US20190381103A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#22 | 2018-08-09

US20180222961A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#23 | 2018-05-03

US20180117085A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#24 | 2017-02-09

US20170035807A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

InventorID:

1790420 ⎘